SEC Form 4 · accession 0001171843-16-009144
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Noyes
Officer — President and CEO · Director
Period of report
Apr 12, 2016
Accepted (ET)
Apr 13, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2016 | M | 58,742 | $1.91 | A | 58,742 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.91 | Apr 12, 2016 | M | 58,742 | D | — | Apr 19, 2016 | Common Stock, $0.001 par value | 58,742 | 0 | D |
Explanation of responses
- F1The option was granted on April 19, 2006. All shares underlying the option have vested.